European Lung Cancer Working Party. Clinical Practice Guidelines. Small Cell Lung Cancer: V. Extensive disease

Authors

  • Costas G. Alexopoulos
  • Marie-Claude Berchier
  • Thierry Berghmans
  • Yves Bonduelle
  • Benoit Colinet
  • Therry Collon
  • Michel Dusart
  • Xavier Ficheroulle
  • Vicente Giner
  • Aekaterini A. Kotsori
  • Jean Jacques Lafitte
  • Nathalie Leclercq
  • Jacques Lecomte
  • Ingrid Louviaux
  • Eveline Markiewicz
  • Celine Mascaux
  • Marianne Paesmans
  • Michel Richez
  • Marlin Roelandts
  • Jean Paul Sculier
  • Paul Van Houtte
  • Patricia Wackenier

DOI:

https://doi.org/10.2015/hc.v2i3.41

Abstract

The present guidelines on the management of extensive disease small cell lung cancer (SCLC) were formulated by the ELCWP in October 2007. They are designed to answer the following nine questions: 1) What is the definition of extensive disease? 2)What are the active drugs? 3) What is the best induction regimen? 4) Is there a role for maintenance chemotherapy? 5) Is there a role for dose-intensive chemotherapy? 6) Is there a role for the use of haemopoietic growth factors and stem cells support? 7) Is there a role for alternating or sequential chemotherapy? 8) Is there a role for biological treatments? 9) Is there a place for second-line chemotherapy?

Downloads

Issue

Vol. 2 No. 3 (2007)

Section

Clinical Practice Guidelines

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).